Skip to main content

Peer Review reports

From: Treatment for Covid-19 with SARS-CoV-2 neutralizing antibody BRII-196(Ambavirumab) plus BRII-198(Lomisivir): a retrospective cohort study

Original Submission
15 Jul 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
1 Jan 2024 Reviewed Reviewer Report
12 Feb 2024 Reviewed Reviewer Report - Yusuf Emre Ozdemir
25 Feb 2024 Reviewed Reviewer Report - Fatih Çölkesen
6 Mar 2024 Author responded Author comments - An Zhang
Resubmission - Version 3
6 Mar 2024 Submitted Manuscript version 3
14 Mar 2024 Reviewed Reviewer Report
18 Mar 2024 Reviewed Reviewer Report - Fatih Çölkesen
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
10 Apr 2024 Editorially accepted
19 Apr 2024 Article published 10.1186/s40360-024-00753-7

You can find further information about peer review here.

Back to article page